|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Rheumatoid vasculitis with rheumatoid arthritis
ICD-10 (CM) Code and Descriptor
|
M05.20 |
Rheumatoid vasculitis with rheumatoid arthritis of unspecified site
|
M0520 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 28.92%
|
19.72%
|
13.35%
|
11.41%
|
8.45%
|
4.28%
|
4.20%
|
2.98%
|
1.53%
|
1.27%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M05.20*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
304
|
304
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
291
|
291
|
|
80053
|
COMPREHEN METABOLIC PANEL |
238
|
238
|
|
96413
|
CHEMO IV INFUSION 1 HR |
222
|
222
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
184
|
184
|
|
86140
|
C-REACTIVE PROTEIN |
182
|
182
|
|
85652
|
RBC SED RATE AUTOMATED |
134
|
134
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
121
|
224
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
117
|
127
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
108
|
108
|
|
J1745
|
INFLIXIMAB NOT BIOSIMIL 10MG |
88
|
2,930
|
|
J0129
|
ABATACEPT INJECTION |
85
|
6,250
|
|
J3262
|
TOCILIZUMAB INJECTION |
84
|
30,393
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
72
|
95
|
|
82565
|
ASSAY OF CREATININE |
67
|
67
|
|
97110
|
THERAPEUTIC EXERCISES |
52
|
120
|
|
J2930
|
METHYLPREDNISOLONE INJECTION |
49
|
57
|
|
80061
|
LIPID PANEL |
49
|
49
|
|
85651
|
RBC SED RATE NONAUTOMATED |
49
|
49
|
|
J9312
|
INJ., RITUXIMAB, 10 MG |
48
|
4,552
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M05.20 related to the following DRG Codes:
545-547
|
